Glaxo Teams With Philip Morris-Backed Biotech on Covid Vaccine

Bookmark
(Bloomberg) -- GlaxoSmithKline Plc is collaborating on an experimental Covid-19 vaccine with Medicago, a biotechnology company partly owned by tobacco giant Philip Morris International Inc.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.